|
|
|||
|
||||
OverviewWe clarify the carcinogenic functions of some signalling pathways in liver cancer, particularly hepatocellular carcinoma (HCC), and the status of inhibitor research as it stands at the moment. This calls for the urgent creation of novel, focused strategies as well as the removal of current obstacles. In an attempt to improve the patients' unsatisfactory prognostic outlook, this book aims to clarify the use of targeted therapy in advanced liver cancer and the mechanisms underlying the phenomenon of resistance that arises frequently when treating HCC. Full Product DetailsAuthor: Ahmed A Abd-RabouPublisher: LAP Lambert Academic Publishing Imprint: LAP Lambert Academic Publishing Dimensions: Width: 15.20cm , Height: 0.70cm , Length: 22.90cm Weight: 0.186kg ISBN: 9786208222536ISBN 10: 6208222532 Pages: 120 Publication Date: 15 October 2024 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||